A prospective study of human papillomavirus (HPV) testing to resolve uncertainty in colposcopy

Cytopathology

Volumn 24, Issue 5, 2013, Pages 309-313

  Bowring, J ^a   Albrow, R ^b   Fisher, A ^c   Downey, G ^d   Cullimore, J ^e   Patnick, J ^f   Walker, P G ^g   Kitchener, H C ^b  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d CITY HOSPITAL   (United Kingdom)

^e GREAT WESTERN HOSPITAL   (United Kingdom)

^f NATIONAL HEALTH SERVICE   (United Kingdom)

^g ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Colposcopy; Cytology; Follow up; Human papillomavirus testing

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; CYTODIAGNOSIS; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TESTING; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SERODIAGNOSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

COLPOSCOPY; CYTOLOGY; FOLLOW-UP; HUMAN PAPILLOMAVIRUS TESTING;

ADULT; AGED; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; PROSPECTIVE STUDIES; VAGINAL SMEARS;

EID: 84884678448     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2012.01003.x     Document Type: Article

References (8)

1. Kjær SK, Frederiksen K, Munk C, Iftner T. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst 2010;102:1478-88.
2. Freeman-Wang T, Walker P. Psychological aspects of colposcopy. CME J Gynecol Oncol 2005;10:123-6.
3. Galaal K, Deane K, Sangal S, Lopes AD. Interventions for reducing anxiety in women undergoing colposcopy. Cochrane Database Syst Rev 2007; Jul 18 (3): CD006013.
4. Arbyn M, Sasieni P, Meijer CJ et al. Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006;24(3 Suppl):S78-89.
5. Sargent A, Bailey A, Turner A et al. Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J Clin Microbiol 2010;48:554-8.
6. Department of Health Improving Outcomes: A Strategy for Cancer. London: Department of Health; 2011. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_123394.pdf (Accessed 1 July 2012).
7. Kelly RS, Walker P, Kitchener H, Moss SM. Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative/human papillomavirus-positive women with low-grade cytological abnormalities. BJOG 2012;119:20-5.
8. The NHS Information Centre Cervical Screening Programme - England, 2010-2011. Leeds: The Health and Social Care Information Centre; 2011. Available at: http://www.ic.nhs.uk/webfiles/publications/008_Screening/cervscreen1011/Cervical_Bulletin_2010_11_v1_1.pdf (Accessed 1 April 2012).